|
77
|
301
|
8gzbA |
Sars-cov-2 3clpro |
|
74
|
299
|
8sg6A |
Sars-cov-2 main protease (mpro) h163a mutant reduced with 20mm tcep |
|
90
|
300
|
7wqbA |
Sars-cov-2 main protease mutant (p168a) in complex with mg-132 |
|
85
|
306
|
7ur9A |
Sars-cov2 main protease in complex with inhibitor cdd-1845 |
|
80
|
301
|
8gfnA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with bbh1 |
|
86
|
302
|
8gfrA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with nbh2 |
|
83
|
302
|
8gfoA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with gc373 |
|
82
|
302
|
8gfkA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304 |
|
82
|
302
|
8gfuA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with nirmatrelvir (nmv) |
|
75
|
305
|
8didA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
80
|
304
|
8diiA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
82
|
300
|
8digA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
77
|
300
|
8difA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
84
|
305
|
8dieA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
85
|
304
|
8dibA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
82
|
304
|
8dihA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
80
|
305
|
8dicA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
79
|
298
|
8husA |
Crystal structure of sars main protease in complex with s217622 |
|
88
|
299
|
8huxA |
Crystal structure of sars-cov-2 main protease p132h mutant in complex with s217622 |
|
84
|
297
|
8huwA |
Crystal structure of sars-cov-2 main protease k90r mutant in complex with s217622 |
|
81
|
297
|
8huvA |
Crystal structure of sars-cov-2 main protease g15s mutant in complex with s217622 |
|
82
|
298
|
8hurA |
Crystal structure of sars-cov-2 main protease in complex with s217622 |
|
83
|
304
|
8sxoA |
Crystal structure of sars-cov-2 main protease (mpro) h164i mutant |
|
88
|
306
|
8skhA |
Co-structure of sars-cov-2 (covid-19 with covalent pyrazoline based inhibitors |
|
86
|
305
|
8sk4A |
Co-structure of sars-cov-2 (covid-19 with covalent pyrazoline based inhibitors) |
|
84
|
302
|
8spjA |
Crystal structure of sars-cov-2 main protease (mpro) n28t mutant |
|
81
|
306
|
8dk8A |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
80
|
301
|
8okkA |
Crystal structure of f2f-2020184-00x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
81
|
301
|
8oknA |
Crystal structure of f2f-2020198-00x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
77
|
301
|
8oklA |
Crystal structure of f2f-2020185-01x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
78
|
301
|
8okmA |
Crystal structure of f2f-2020197-00x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
92
|
306
|
8dklA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
86
|
306
|
8ej7A |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
81
|
306
|
8dkhA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
89
|
306
|
8di3A |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
92
|
306
|
8dkkA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
81
|
306
|
8dmnA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
85
|
306
|
8dkjA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
81
|
306
|
8djjA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
76
|
306
|
8eirA |
Sars-cov-2 polyprotein substrate regulates the stepwise mpro cleavage reaction |
|
79
|
306
|
8ej9A |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
59
|
305
|
8ekeA |
Cryo-em structure of sars cov-2 mpro wt protease |
|
74
|
306
|
8dkzA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
0
|
10
|
8eirC |
Sars-cov-2 polyprotein substrate regulates the stepwise mpro cleavage reaction |
|
87
|
306
|
7sh8A |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi88 |
|
87
|
301
|
8ignA |
Crystal structure of sars-cov-2 main protease in complex with ray1216 |
|
86
|
306
|
7sh9A |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi86 |
|
82
|
306
|
7sh7A |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi87 |
|
84
|
301
|
8igoA |
Crystal structure of apo sars-cov-2 main protease |
|
87
|
303
|
8dzbA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor 11 |
